New robotic surgery technique aims to ease recovery for rectal cancer patients
NCT ID NCT06454201
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a new robotic surgery method called natural orifice specimen extraction surgery (NOSES) for middle rectal cancer. In this approach, the removed tumor is taken out through the anus instead of a large abdominal cut. The study involved 150 patients and compared NOSES to standard robotic surgery, looking at complications, pain, and recovery time. The goal was to see if NOSES is safe and offers benefits like less pain and shorter hospital stays.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- robotic natural orifice specimen extraction surgery (NOSES)
- What this could lead to
- If successful, this approach could offer a less invasive surgical option for middle rectal cancer, potentially reducing pain and shortening hospital stays.
- What could go wrong
- This is a completed study with 150 participants, but it focuses on short-term outcomes only. Long-term benefits and risks are not yet known, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIDDLE RECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
the First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, 330000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.